{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "72064-150",
      "generic_name": "avapritinib",
      "labeler_name": "Blueprint Medicines Corporation",
      "brand_name": "Ayvakit",
      "active_ingredients": [
        {
          "name": "AVAPRITINIB",
          "strength": "50 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "72064-150-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-150-30)",
          "marketing_start_date": "20210616",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "c6bf8968-b0ec-46f8-91ca-f73ff9b1f1c1",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210616",
      "product_id": "72064-150_c6bf8968-b0ec-46f8-91ca-f73ff9b1f1c1",
      "application_number": "NDA212608",
      "brand_name_base": "Ayvakit",
      "pharm_class": [
        "Bile Salt Export Pump Inhibitors [MoA]",
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2C9 Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
        "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Tyrosine Kinase Inhibitors [MoA]"
      ]
    }
  ]
}